Independent review of E2100 progression-free survival (PFS) with the addition of bevacizumab (B) to paclitaxel (P) as initial chemotherapy for metastatic breast cancer (MBC) Meeting Abstract
| Authors: | Klencke, B. J.; Bhattacharya, S.; Samant, M. K.; Gralow, J. R.; Dickler, M. N.; Cobleigh, M. A.; Perez, E. A.; Shenkier, T. N.; Davidson, N. E.; Miller, K. D. |
| Abstract Title: | Independent review of E2100 progression-free survival (PFS) with the addition of bevacizumab (B) to paclitaxel (P) as initial chemotherapy for metastatic breast cancer (MBC) |
| Meeting Title: | 44th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 26 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2008 May 30-Jun 3 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2008-05-20 |
| Start Page: | 50s |
| Language: | English |
| ACCESSION: | WOS:000208457400311 |
| DOI: | 10.1200/jco.2008.26.15_suppl.1036 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 1036 -- Source: Wos |
